tm logo
SUPERDONOR
Live/Registered
REGISTERED

on 05 Sep 2023

Last Applicant/ Owned by

2 Ilan Ramon

Nes Ziyyona

IL

7403635

Serial Number

97196369 filed on 30th Dec 2021

Registration Number

7153599 registered on 05th Sep 2023

in the Principal Register

Correspondent Address

YAEL ROUACH CABILLY; CABILLY & CO.

HERZLIYA;

4673300

ISRAEL,

Filing Basis

No Filing Basis

Disclaimer

"SUPER DONOR"

SUPERDONOR

"SUPER DONOR" SUPER DONOR Dietary supplements; food supplements; nutritional supplements; dietary and nutritional supplements; dietary food supplemental drinks; dietary food supplements; dietary supplement drink mixes in the nature of vitamin and mineral beverages; dietary supplements for animals; dietary supplements for human consumption; dietary supplements with a cosmetic effect; powdered fooRead More

Classification Information


Class [005]
Pharmaceutical Products


Dietary supplements; food supplements; nutritional supplements; dietary and nutritional supplements; dietary food supplemental drinks; dietary food supplements; dietary supplement drink mixes in the nature of vitamin and mineral beverages; dietary supplements for animals; dietary supplements for human consumption; dietary supplements with a cosmetic effect; powdered food supplements; powdered nutritional supplements; probiotic supplements; probiotic dietary supplements; probiotic preparations for medical use; sedatives; antifungal medication in the nature of antifungal preparations; medicines for alleviating constipation; pharmaceutical preparations for treating allergies; pharmaceutical preparations for the treatment of hormonal disorders; medicines for treating intestinal disorders; preparations for treating colds; burn relief medication; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical antitussive-cold preparations; non-prescription medicines, namely, medicinal preparations in the nature of pills, tablets, capsules, caplets, liquid drops, sachets, oral liquids, suspensions, liquids, semi-solids, creams, syrups, ointments, lotions, gels, sprays, emulations, oils, pessaries, suppositories, granules and films for the treatment of cardiovascular disorders, antibiotic associated diarrhea, gastrointestinal disorders, neurological disorders, ophthalmological disorders, neurodegenerative disorders, cognitive impairment, damaged skin and tissue, pulmonary disorders, for supporting oncology treatments, for the prevention and treatment of allergies, for the prevention and treatment of bacterial vaginosis and vaginal related women health disorders, for the prevention and treatment of urogenital related health disorders, for alleviating constipation, for the prevention and treatment of dysbiosis, for enrichment of beneficial bacteria; medicines for dental purposes; medicines for veterinary purposes namely, anti-infective products for veterinary use, veterinary pharmaceutical preparations and substances for the treatment of cardiovascular disorders, antibiotic associated diarrhea, gastrointestinal disorders, neurological disorders, ophthalmological disorders, neurodegenerative disorders, cognitive impairment, damaged skin and tissue, pulmonary disorders, for supporting oncology treatments, for the prevention and treatment of allergies, for the prevention and treatment of vaginal related health disorders, for the prevention and treatment of urogenital related health disorders, for alleviating constipation, for the prevention and treatment of dysbiosis, for enrichment of beneficial bacteria; pain relief medication; decongestant capsules; herbal medicines, namely, medicinal herbal preparations, herbal pharmaceutical preparations and herbal substances for the treatment of cardiovascular disorders, antibiotic associated diarrhea, gastrointestinal disorders, neurological disorders, ophthalmological disorders, neurodegenerative disorders, cognitive impairment, damaged skin and tissue, pulmonary disorders, for supporting oncology treatments, for the prevention and treatment of allergies, for the prevention and treatment of vaginal related health disorders, for the prevention and treatment of urogenital related health disorders, for alleviating constipation, for the prevention and treatment of dysbiosis, for enrichment of beneficial bacteria; antihypertensives; antitussives; diarrhea medication; antiflatulants ; antiemetics; antivirals; pharmaceutical preparations for the treatment of allergic rhinitis; pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations and substances for the treatment of gastrointestinal diseases; pharmaceutical preparations and substances for the treatment of damaged skin and tissue; medicines for treating gastrointestinal diseases

Mark Details


Serial Number

No 97196369

Mark Type

No Service/Collective Mark

Attorney Docket Number

No NMD-T-106-US

44D Filed

Yes

44D Current

No

44E filed

Yes

44E Current

Yes

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

16.03.06 -

Magnifying glasses, jeweler's loupes

26.01.13 -

Two circles

26.01.21 -

Circles that are totally or partially shaded

26.17.01 -

Straight line(s), band(s) or bar(s)

26.17.06 -

Diagonal line(s), band(s) or bar(s)

27.03.05 -

Representations of objects forming letters or numerals, including punctuation

Description of Design Search

The mark consists of the wording "SUPERDONOR" in stylized font, with a dot to the left side of the initial "S" and also in the center of the second "O" of DONOR; the first "O" of DONOR is in a shape of a lens of a magnifying glass.

Legal History


Show more

Status DateAction Taken
05th Sep 2023REGISTERED-PRINCIPAL REGISTER
05th Sep 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
20th Jun 2023PUBLISHED FOR OPPOSITION
20th Jun 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
31st May 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
15th May 2023ELECTRONIC RECORD REVIEW COMPLETE
12th May 2023ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
09th May 2023APPROVED FOR PUB - PRINCIPAL REGISTER
10th Apr 2023TEAS/EMAIL CORRESPONDENCE ENTERED
09th Apr 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED